Pacira | PCRX - Ordinary Share Capital


Pacira reported $39.31M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Astellas Pharma JPY 1.79B 81K Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 2.41B 1.74M Dec/2025
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 39.31M 1.81M Mar/2026
Perrigo USD 138.1M 500K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025
Xoma USD 87K 1000 Jun/2024
Zoetis USD 420.35M 4.58M Mar/2026